We know for sure there's no time-release coating, but I'm unsure about enteric coating. It may just be that the makers of retigabine are concerned you're getting exactly the right dosage: http://www.webmd.com/healthy-aging/news/20040519/cutting-pills-in-half-could-pose-problems mentions problems with dosing.OK enough on this, though I guess I am at least going to try and decide withing the next few days whether to get some Potiga. For sure though I intend to 'disobey' the instructions and cut 100 mg pills into 50's. I can see no reason why this is given such emphasis by GSK as it is not an enteric-coated pill from what I have found to date or some "multiplex" chemical that needs all parts like can happen in capsules where there are lots of little tiny coloured balls of med making up the 'whole'. Maybe I will phone GSK and try to find out in a roundabout way c/o my "white coat" persona.
Thanks jazz. I am seeing someone ASAP. Not expecting to get an rx but want will try.That's great news! Be sure to tell your neurologist you will have your eyes examined before and every six months while on the drug to make sure you don't get any eye damage. This way he knows you're on the look out for side effects. Physicians are often hesitant to give drugs with serious side effects, especially with a non-threatening condition. That said, if you present yourself as an intelligent, cautious patient--aware of the risks, but suffering greatly--he may agree to give you a trial run.
You need to do a little savvy salesmanship!
Good luck and tell us as soon as you see your neurologist!
The sensible thing seems to wait until the end of the week and hope we have info on the AUT00063 trial. If we don't hear anything, I may try again for Potiga. I'm sick of living with this ringing if I don't have to.
Nothing on Autifony's website yet saying what, when, where the next trails will be
and my chances of getting into Phase II are about zero.
If I was a researcher I sure would not take me, unless I wanted to REALLY test if the stuff worked on a tough nut case.
Even with my relatively short history I completely understand what you mean. The worst part of this condition is not knowing what will cause it to spike and being afraid of social situations / hobbies/ whatever that most people don't think twice about participating in.For me, after all this time, the "ringing" per se as not as bothersome as what it does to my life...On my own, in quiet I can handle it. It's doing almost anything out in the 'world' that is the problem (camping in the wilderness aside). It's too darn noisy out there and thus restricts to a very narrow band of functioning that ain't much of a "life".
I'm hoping to get into the U.S. trial. I'm mildly hard of hearing and under 12 months from onset, so think I will be a good candidate.What will you even get from that trial info? Unless you are willing and able to get into the trial there is no reason to delay getting retigabine.
Anyway does anyone have any info on how to get onto AUT00063 trial?
I was able to get a potiga prescription very easily, it almost seemed "too easy". My doctor told me to check with a neurologist, the first neurologist I found on google who took my insurance and was able to see me quickly said "oh sure Potiga, this would be an off label use, that sounds fine". He wants me to start at 100mg/day and see what happens.
Because I've been burned by drugs in the past, and only ~10k people in the world have taken this stuff ever as far as I can tell - so there are bound to be bizarre edge case interactions that are not documented yet.
I've also got to do some more soul searching about what I really want to do. I was basically looking for a neurologist's opinion on this, and not expecting to get a prescription so quickly. The other thing I've been considering is just going back on benzos because I know from experience that a pretty low dose of valium (maybe 6-8mg) almost completely silences my tinnitus. So, if I am at the point of wanting to try a drug for this again, then I have to weigh the wealth of data about the long-term risks of benzos, against the lack of data about a novel drug that's only been on the market for 5 years.
This stuff (Potiga) has only existed as a prescription since 2009, has been used by a pretty small number of people, and has a black box warning on it. It's known to cause seizures if the dose is reduced too quickly. Anyone who doesn't think it's potentially a very dangerous thing to be messing around with is kidding themselves.
If I was going to be on something long term, I would absolutely, unquestionably, choose valium over Potiga. The thing that is tantelizing to me about Potiga is the theory that it could be used relatively short-term to cause a long-term reduction in the ringing. But, that's a very, very theoretical idea.
(emphasis mine)To ascertain whether the effects of RTG/EZG were selective for KCNQ channels over other K+ channels, a range of functional electrophysiological studies have been conducted on exemplar channels from other families that make up the K+ channel superfamily (Alexander et al., 2008). RTG/EZG was shown to be without significant activity at members of the 2TM K+ family of channels (e.g., inward rectifiers KIR 2.1 [IRK1] or KIR 3.1) as well as 4TM family and the 2-pore domain channels, such as K2P1.1 (TWIK1) at concentrations ≤100 μm. Members of the 6TM family e.g., Kv1.5, hERG, which includes voltage-gated [Kv] channels and EAG and Ca2+ activated channels (in addition to KCNQ channels), were also relatively unaffected, with IC50 values of >50 μm and 59 μm, respectively (GSK/Valeant data on file, personal communications). These data emphasize the remarkably selective action of RTG/EZGon a subset of K+ channels, namely KCNQ2–5 over the broader superfamily of K+ channels that occur in humans.
Because I've been burned by drugs in the past, and only ~10k people in the world have taken this stuff ever as far as I can tell - so there are bound to be bizarre edge case interactions that are not documented yet.
I've also got to do some more soul searching about what I really want to do. I was basically looking for a neurologist's opinion on this, and not expecting to get a prescription so quickly. The other thing I've been considering is just going back on benzos because I know from experience that a pretty low dose of valium (maybe 6-8mg) almost completely silences my tinnitus. So, if I am at the point of wanting to try a drug for this again, then I have to weigh the wealth of data about the long-term risks of benzos, against the lack of data about a novel drug that's only been on the market for 5 years.
This stuff (Potiga) has only existed as a prescription since 2009, has been used by a pretty small number of people, and has a black box warning on it. It's known to cause seizures if the dose is reduced too quickly. Anyone who doesn't think it's potentially a very dangerous thing to be messing around with is kidding themselves.
If I was going to be on something long term, I would absolutely, unquestionably, choose valium over Potiga. The thing that is tantelizing to me about Potiga is the theory that it could be used relatively short-term to cause a long-term reduction in the ringing. But, that's a very, very theoretical idea.
I see many questions about the drugs acting on potassium channels.
Here is a technical but clear view on some of those drugs. (Flupirtine, Retigabine, AUT00063)
First and most importantly, potassium channel modulators should not be compared, there is a ton of parameters and subtilities that can change drastically the impact of one drug.
Flupirtine acts mainly on the Kv7.3 , retigabine specifically acts on the neuronally expressed KCNQ2-KCNQ5 (Kv7.2-Kv7.5) channels, AUT00063 will act on the Kv3 channels.
Talking from a neuronal perspective, Kv7 and Kv3 mediate the channels and more precisely the action potential.
The action potential is an electrical signal generated near the cell body of a neuron that propagates along the axon to the axon terminals.
After an acoustic trauma, or after taking some drugs such as quinine there is an interference with the excitability of spiral ganglion neurons (The evil glutamate is guilty ). The membrane potential changes and the modification of the action-potential waveform induced by the problem put the individual in a T. state.
Going back to the potassium channels, Kv7 channels primarily control the interspike interval with a limited effect of the repolarization. Kv3 channels control the repolarization of the action potential and are expected to induce a new state.
The idea is to open the right channels to lead to a neuronal hyperpolarization, thereby stabilizing the membrane potential and decreasing excitability.(No or very little Tinnitus)
Conclusions:
- Despite a drug being potassium channel opener, it has to be very precise to work.
- Flupirtine doesn't act on any sub unit related to T. ( So no possible impact)
- Retigabine acts on interspike interval, meaning less T. spikes and it can possibly repolarize the action potential for some people. But the sub unit range is too wide with numerous side effects. (so it can work to stabilize T. and decrease it to some extent, but is not specific enough to be viable.)
- AUT00063 acts directly on the repolarization and is much more precise, so it's a viable solution providing it works as expected
Drugs such as benzo, lorazepam accelerate brain plasticity, doctors who prescribe it to accute T. patients are idiots.
A well known article demonstrates the following point on other area of the brain, but the idea is the same:
"These findings indicate that a decrease in GABA-related inhibition facilitates practice-dependent plasticity in the human motor cortex, whereas an increase depresses it."
http://www.ncbi.nlm.nih.gov/pubmed/11353733
Lorazepam increased your plasticity and you did not benefit from the time your brain process the information to restructure the brain. In other word, the natural decrease of T. perception thx to plasticity lag.
This is just a much more elegant way to say what I wrote above, Lidocaine or Phenytoin are strongly linked to sodium / potassium channels. Lidocaine is a sodium blocker and Phenytoin reduces the amplitude of sodium-dependent action potentials through enhancing steady state inactivation of sodium channels.
In simple words they close the sodium valve in the brain, and here in our case in the auditory system. By doing so, sodium channels are at the level of the defective potassium channel common to chronic T. sufferers. (THis is why it turns off the T. for a moment, but it's not the good philophy, and it's not targeting the specific P channel).
In fact, as soon as the drug is gone sodium become dominant again and prevent the auditory system to go back in a resting state. (Turn on big speakers and turn the sound up without any music or noise, you will hear a continuous buzz in the speaker. THis is pretty much what happens for us).
The big difference with the AUT00063 is that it doesn't try to reduce sodium channels to a defective state, but it helps potassium channels to go back to a normal state of activity. Over the time it's going to train it again to work normally because the circuit itself is not damaged as demonstrated in this article:
http://informahealthcare.com/doi/abs/10.3109/14992027.2013.846482
It's like a manual car that stalled, it's nothing more than to protect the engine that it does so, it doesn't mean your car is broken, you just have to turn the key to start the engine again. It's pretty much what AUT00063 is trying to do.
To be fair, linearb is right that the drug has only been around since 2009, and despite the best intentions of doctors, it has produced some potentially lifelong side effects, possibly only after long-term use (4+ years). I went to a neurologist's office, and was told by the doctor and his PA that they don't prescribe retigabine after the problems their patients had while using it.Seems to me like you are looking for someone to talk you into taking it as you are scared. This is something made for people with epilepsy and they take it for life so it is not something that is made to be used short duration. That means the drug safety profile must be higher and those people using it are taking it to make their lives normal, not to live under a glass bell. You are worrying too much.
Retigabine didn't work well enough for their epilepsy patients compared to the frequency and severity of side effects.
benryu said:Drugs such as benzo, lorazepam accelerate brain plasticity, doctors who prescribe it to accute T. patients are idiots.
A well known article demonstrates the following point on other area of the brain, but the idea is the same:
"These findings indicate that a decrease in GABA-related inhibition facilitates practice-dependent plasticity in the human motor cortex, whereas an increase depresses it."
http://www.ncbi.nlm.nih.gov/pubmed/11353733
Is there a list of the people who have taken retigabine in here? I would like to compile a list of people.
@Mpt, @Christian78 ? Am I missing others?
Can you expand on what you mean here? Do you think using benzos for acute tinnitus literally makes it more likely to become a chronic condition?
I suspect that my history of benzo use may have made my tinnitus more significant; at this point I've been off of them for about 16 months, with no real change in the ringing. But, I have read accounts of people with no preexisting tinnitus who developed it as a result of withdrawal from benzos and did recover from it, but in some cases it took 3-4 years after withdrawal from the benzo. One of the big reasons I'm reluctant to just go back on valium now to deal with this, is that if I do I will never know if I might have improved on my own, given more time. I'm curious what you think about all of that.
edit: err - the way I read that is, that benzos decrease plasticity, not increase it? Benzos increase the action of GABA, doesn't that mean that the presence of a benzo causes an increase in GABA-related inhibition, which would decrease the specific kind of plasticity being studied here? Also, how applicable is this to sensory nerves?
@Viking is another one; he had good results, but had to quit due to side effects.